News and Updates for Healthcare Professionals
NIH-supported study links poor sleep to increased risk of COPD flare-ups
Study is one of the largest to look at the links between sleep quality and COPD flare-ups.
Prediabetes and Diabetes Screening Eligibility and Detection in US Adults After Changes to US Preventive Services Task Force and American Diabetes Association Recommendations
Prediabetes and type 2 diabetes have reached epidemic levels and are associated with major morbidity and mortality. The US Preventive Services Task Force (USPSTF) and the American Diabetes Association (ADA) recently recommended lowering the starting age for diabetes screening to 35 years to facilitate earlier detection and treatment.1,2 We estimated the proportion of asymptomatic US adults eligible…
News and Updates for the Patient and Family
Improving Nutrition to Turn the Tide on Diet-Related Chronic Disease
March is National Nutrition Month, and the U.S. Food and Drug Administration is shining a spotlight on the importance of good nutrition and the big impact it has on improving people’s lives and lowering the enormous costs of diet-related chronic diseases. Each year, more than a million Americans die from diet-related diseases like cardiovascular disease, diabetes and certain forms of cancers.…
Johns Hopkins Lipitz Center Winter 2022 Newsletter
The Roger C. Lipitz Center for Integrated Health Care is pleased to share the newly released Engaging and Supporting Family Caregivers in Care Delivery issue brief in this Winter 2022 Lipitz Quarterly Newsletter
November Is National Diabetes Month
Prediabetes is a serious health condition affecting 88 million Americans—more than 1 in 3 people—and most are unaware they have it. People with prediabetes have higher-than-normal blood sugar levels that aren’t yet high enough to be considered diabetes, and data shows that people with prediabetes have a 50% chance of developing type 2 diabetes within 5 to 10 years.
Updated Dietary Guidelines for Americans Toolkit Now Available!
ODPHP has launched our updated toolkit for health professionals, with consumer-friendly fact sheets based on the Dietary Guidelines for Americans, 2020–2025.
AAKP Patient Impact Statement: FDA APPROVAL OF THIRD VACCINE DOSE FOR KIDNEY TRANSPLANT PATIENTS
WASHINGTON, D.C. - "Kidney transplant patients, based on the lifetime immunosuppressive medications they must take to stay alive, remain at severe risk of catastrophic illness and death due to COVID-19. The American Association of Kidney Patients (AAKP) thanks the U.S. Food and Drug Administration (FDA) for incorporating the unique insights of America's kidney transplant recipients and the medical professionals who care for them in their authorization of a third vaccine dose...